CEFAZOLIN SODIUM

Post-LOE

cefazolin sodium

Teva

ANDAINJECTIONINJECTABLE

Approved

Oct 2008

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

CEFAZOLIN SODIUM (cefazolin sodium) by Teva is clinical pharmacology: after intramuscular administration of cefazolin for injection to normal volunteers, the mean serum concentrations were 37 mcg/ml at 1 hour and 3 mcg/ml at 8 hours following a 500 mg dose, and 64 mcg/ml at 1 hour and 7 mcg/ml at 8 hours following a 1 gram dose. Approved for the following serious infections due to susceptible organisms, development of drug-resistant bacteria, maintain the effectiveness of cefazolin for injection and 5 more indications. First approved in 2008.

Drug data last refreshed 19h ago

Mechanism of Action

CLINICAL PHARMACOLOGY: After intramuscular administration of Cefazolin for Injection to normal volunteers, the mean serum concentrations were 37 mcg/mL at 1 hour and 3 mcg/mL at 8 hours following a 500 mg dose, and 64 mcg/mL at 1 hour and 7 mcg/mL at 8 hours following a 1 gram dose. Studies have…

Worked on CEFAZOLIN SODIUM at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

CEFAZOLIN SODIUM

Mechanism of Action

Indications (8)